Records 1 - 8
| Expanding the phenotype of E318K (c.952G?>?A) MITF germline mutation carriers: case series and review of the literature.
Hereditary cancer in clinical practice 2021 Jul 19 (1): 32.
Oliveira Leandro Jonata Carvalho, Gongora Aline Bobato Lara, Lima Fabiola Ambrosio Silveira, Canedo Felipe Sales Nogueira Amorim, Quirino Carla Vanessa, Pisani Janina Pontes, Achatz Maria Isabel, Rossi Benedito Mau
| Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.
JCO global oncology 2021 Jun 7 849-861.
Gupta Sudeep, Rajappa Senthil, Advani Suresh, Agarwal Amit, Aggarwal Shyam, Goswami Chanchal, Palanki Satya Dattatreya, Arya Devavrat, Patil Shekhar, Kodagali Roh
| Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Jul .
Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa
| Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.
Japanese journal of clinical oncology 2018 Jul .
Sakurada Shoko, Watanabe Yoh, Tokunaga Hideki, Takahashi Fumiaki, Yamada Hidekazu, Takehara Kazuhiro, Yaegashi Nob
| Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Familial cancer 2013 Dec 12 (4): 719-40.
Casey Murray Joseph, Bewtra Chhanda, Lynch Henry T, Snyder Carrie, Stacy Mark, Watson Patri
| Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
Gynecologic oncology 2010 Sep 118 (3): 299-302.
Vicus Danielle, Finch Amy, Cass Ilana, Rosen Barry, Murphy Joan, Fan Isabel, Royer Robert, McLaughlin John, Karlan Beth, Narod Steven
| Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
Gynecologic oncology 2010 Aug 118 (2): 155-9.
Vicus Danielle, Finch Amy, Rosen Barry, Fan Isabel, Bradley Linda, Cass Ilana, Sun Ping, Karlan Beth, McLaughlin John, Narod Steven A,
| High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (22): 7569-73.
Maehle Lovise, Apold Jaran, Paulsen Torbjørn, Hagen Bjørn, Løvslett Kjell, Fiane Bent, Van Ghelue Marijke, Clark Neal, Møller P